IDYA vs CELC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
IDYA · IDEAYA Biosciences$31.24 ▲ 1.93%
CELC · Celcuity$66.79 ▲ 4.29%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- IDYA +1.1%
- CELC -12.9%
Head to head
| Metric | IDYA | CELC |
|---|---|---|
| Price | $31.24 | $66.79 |
| Change today | ▲ 1.93% | ▲ 4.29% |
| Market cap | $3.02B | $3.28B |
| Return, 3 months | -15.0% | -26.4% |
| Return, year to date | -9.6% | -33.0% |
| Return, 1 year | +3.3% | -10.4% |
| P/E (TTM) | – | – |
| P/B | 2.8 | -44.3 |
| P/E percentile vs own 5y | 43rd | 20th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | -45.1% | -74.2% |
| Gross margin | – | – |
| Operating margin | -92.7% | – |
| Net margin | -74.8% | – |
| Return on equity | -16.2% | -1,433.7% |
| Analyst target vs. price | +62.0% | +133.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 37 | 46 |
| 30-day volatility | 43.5% | 61.2% |
| Max drawdown, 1 year | -27.8% | -61.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CELC is the largest of the group by market value.
- IDYA has returned the most over the past year.
- IDYA has been the calmest stock over the last 30 days.